首页> 美国卫生研究院文献>Oncotarget >Small molecule-mediated induction of miR-9 suppressed vascular smooth muscle cell proliferation and neointima formation after balloon injury
【2h】

Small molecule-mediated induction of miR-9 suppressed vascular smooth muscle cell proliferation and neointima formation after balloon injury

机译:小分子介导的miR-9诱导抑制了球囊损伤后血管平滑肌细胞增殖和新内膜形成

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pathologic proliferation and migration of vascular smooth muscle cells (VSMCs) exacerbate cardiovascular disease. MicroRNAs (miRNAs), as endogenous inhibitors of protein synthesis, are expected to modulate pathologic proliferation of VSMCs. Here we report that both platelet-derived growth factor receptor (PDGFR) targeting miR-9 and a small molecule that increases miR-9 can inhibit the serum-induced proliferation of VSMCs. First, based on miRNA-target prediction databases and empirical data, we have selected miR-9 as a potent anti-proliferative miRNA in VSMCs. Further examination indicated that miR-9 directly targets PDGFR disrupting downstream signaling cascades, and this resulted in inhibition of VSMC proliferation and migration. Exogenous delivery of miR-9 inhibited VSMC proliferation in vitro, and a small molecule that increased miR-9 expression also inhibited neointima formation following balloon injury in vivo. We provide evidence of miRNA-mediated modulation of VSMC proliferation and further demonstrate that small molecule-mediated regulation of miRNA targeting a key regulator of VSMC proliferation is a viable therapeutic strategy for treating vascular disease involving pathologic VSMC proliferation such as restenosis.
机译:血管平滑肌细胞(VSMC)的病理性增殖和迁移加剧了心血管疾病。 MicroRNA(miRNA)作为蛋白质合成的内源性抑制剂,有望调节VSMC的病理性增殖。在这里,我们报道靶向miR-9的血小板衍生生长因子受体(PDGFR)和增加miR-9的小分子均可以抑制血清诱导的VSMC增殖。首先,基于miRNA目标预测数据库和经验数据,我们选择miR-9作为VSMC中有效的抗增殖miRNA。进一步的检查表明,miR-9直接靶向破坏下游信号传导级联的PDGFR,这导致VSMC增殖和迁移受到抑制。 miR-9的外源传递在体外抑制VSMC增殖,而增加miR-9表达的小分子在体内也可抑制球囊损伤后新内膜的形成。我们提供miRNA介导的VSMC增殖调控的证据,并进一步证明以小分子介导的针对VSMC增殖关键调节剂的miRNA调控是治疗涉及病理性VSMC增殖(如再狭窄)的血管疾病的可行治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号